Loading…

Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions

Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered states close to the thick filament backbone. It remains elusive whether thes...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 2024-02, Vol.121 (8), p.e2314914121
Main Authors: Ma, Weikang, Del Rio, Carlos L, Qi, Lin, Prodanovic, Momcilo, Mijailovich, Srboljub, Zambataro, Christopher, Gong, Henry, Shimkunas, Rafael, Gollapudi, Sampath, Nag, Suman, Irving, Thomas C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3
cites cdi_FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3
container_end_page
container_issue 8
container_start_page e2314914121
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 121
creator Ma, Weikang
Del Rio, Carlos L
Qi, Lin
Prodanovic, Momcilo
Mijailovich, Srboljub
Zambataro, Christopher
Gong, Henry
Shimkunas, Rafael
Gollapudi, Sampath
Nag, Suman
Irving, Thomas C
description Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered states close to the thick filament backbone. It remains elusive whether these myosin heads in the state(s) can be recruited in response to physiological stimuli when required to boost cardiac output. We show that cardiac myosins stabilized in these state(s) by mavacamten are recruitable by 1) Ca , 2) increased chronotropy [heart rate (HR)], 3) stretch, and 4) β-adrenergic (β-AR) stimulation, all known physiological inotropic interventions. At the molecular level, we show that Ca increases myosin ATPase activity by shifting mavacamten-stabilized myosin heads from the inactive super-relaxed state to the active disordered relaxed state. At the myofilament level, both Ca and passive lengthening can shift mavacamten-ordered myosin heads from positions close to the thick filament backbone to disordered states closer to the thin filaments. In isolated rat cardiomyocytes, increased stimulation rates enhanced shortening fraction in mavacamten-treated cells. This observation was confirmed in vivo in telemetered rats, where left-ventricular dP/dt an index of inotropy, increased with HR in mavacamten-treated animals. Finally, we show that β-AR stimulation in vivo increases left-ventricular function and stroke volume in the setting of mavacamten. Our data demonstrate that the mavacamten-promoted states of myosin in the thick filament are at least partially activable, thus preserving cardiac reserve mechanisms.
doi_str_mv 10.1073/pnas.2314914121
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10895252</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2926079009</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3</originalsourceid><addsrcrecordid>eNpdkctv1DAQxiMEokvhzA1FcClS044fiZ0TQhUvqYgLnK2J7bCuEjvYzqLlr8fLlvKQLHlG85tvPP6q6imBCwKCXS4e0wVlhPeEE0ruVRsCPWk63sP9agNARSM55SfVo5RuAKBvJTysTphkvKNAN9X3j_uQnK_LwTUH57ducNmaOoxjnTJme5Zenh-iwU3uRykM-3rGHWqcs_XntUZfD7aOVsf1V2NRijYtwSdb51DSkGNYnC5RtnFnfXal9rh6MOKU7JPb-7T68vbN56v3zfWndx-uXl83mvM-N0T2TCDt0CAf7GCGEYThoxkJUI0tawl2wFEKiSBGaTrDmTTGAtcoEA07rV4ddZd1mK3RZXzESS3RzRj3KqBT_1a826qvYacIyL6lLS0Kz48KIWWnki5L6q0O3ludFeUCKJUFOrsdE8O31aasZpe0nSb0NqxJ0Z52IPpiQEFf_IfehDX68gmFYiCpkEwU6vJI6RhSina8ezIBdbBeHaxXf6wvHc_-3vSO_-01-wkt0a0B</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2930827837</pqid></control><display><type>article</type><title>Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions</title><source>PubMed Central</source><creator>Ma, Weikang ; Del Rio, Carlos L ; Qi, Lin ; Prodanovic, Momcilo ; Mijailovich, Srboljub ; Zambataro, Christopher ; Gong, Henry ; Shimkunas, Rafael ; Gollapudi, Sampath ; Nag, Suman ; Irving, Thomas C</creator><creatorcontrib>Ma, Weikang ; Del Rio, Carlos L ; Qi, Lin ; Prodanovic, Momcilo ; Mijailovich, Srboljub ; Zambataro, Christopher ; Gong, Henry ; Shimkunas, Rafael ; Gollapudi, Sampath ; Nag, Suman ; Irving, Thomas C ; Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><description>Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered states close to the thick filament backbone. It remains elusive whether these myosin heads in the state(s) can be recruited in response to physiological stimuli when required to boost cardiac output. We show that cardiac myosins stabilized in these state(s) by mavacamten are recruitable by 1) Ca , 2) increased chronotropy [heart rate (HR)], 3) stretch, and 4) β-adrenergic (β-AR) stimulation, all known physiological inotropic interventions. At the molecular level, we show that Ca increases myosin ATPase activity by shifting mavacamten-stabilized myosin heads from the inactive super-relaxed state to the active disordered relaxed state. At the myofilament level, both Ca and passive lengthening can shift mavacamten-ordered myosin heads from positions close to the thick filament backbone to disordered states closer to the thin filaments. In isolated rat cardiomyocytes, increased stimulation rates enhanced shortening fraction in mavacamten-treated cells. This observation was confirmed in vivo in telemetered rats, where left-ventricular dP/dt an index of inotropy, increased with HR in mavacamten-treated animals. Finally, we show that β-AR stimulation in vivo increases left-ventricular function and stroke volume in the setting of mavacamten. Our data demonstrate that the mavacamten-promoted states of myosin in the thick filament are at least partially activable, thus preserving cardiac reserve mechanisms.</description><identifier>ISSN: 0027-8424</identifier><identifier>ISSN: 1091-6490</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.2314914121</identifier><identifier>PMID: 38346202</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Animals ; BASIC BIOLOGICAL SCIENCES ; Benzylamines - pharmacology ; Biological Sciences ; Calcium ; Calcium ions ; Cardiac output ; Cardiomyocytes ; Enzymatic activity ; Filaments ; Heart rate ; Muscle Contraction ; Myocytes, Cardiac ; Myosin ; Myosin ATPase ; Myosins ; Physiology ; Rats ; Science &amp; Technology - Other Topics ; Stimulation ; Stroke volume ; Uracil - analogs &amp; derivatives ; Ventricle</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2024-02, Vol.121 (8), p.e2314914121</ispartof><rights>Copyright National Academy of Sciences Feb 20, 2024</rights><rights>Copyright © 2024 the Author(s). Published by PNAS. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3</citedby><cites>FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3</cites><orcidid>0000-0001-9535-7114 ; 0000-0002-9761-7888 ; 0000-0003-0556-1213 ; 0000-0003-4848-3323 ; 0000-0003-2640-3548 ; 0000-0002-3770-5798 ; 0000000348483323 ; 0000000195357114 ; 0000000305561213 ; 0000000237705798 ; 0000000326403548 ; 0000000297617888</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895252/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10895252/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38346202$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/servlets/purl/2470228$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Weikang</creatorcontrib><creatorcontrib>Del Rio, Carlos L</creatorcontrib><creatorcontrib>Qi, Lin</creatorcontrib><creatorcontrib>Prodanovic, Momcilo</creatorcontrib><creatorcontrib>Mijailovich, Srboljub</creatorcontrib><creatorcontrib>Zambataro, Christopher</creatorcontrib><creatorcontrib>Gong, Henry</creatorcontrib><creatorcontrib>Shimkunas, Rafael</creatorcontrib><creatorcontrib>Gollapudi, Sampath</creatorcontrib><creatorcontrib>Nag, Suman</creatorcontrib><creatorcontrib>Irving, Thomas C</creatorcontrib><creatorcontrib>Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><title>Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered states close to the thick filament backbone. It remains elusive whether these myosin heads in the state(s) can be recruited in response to physiological stimuli when required to boost cardiac output. We show that cardiac myosins stabilized in these state(s) by mavacamten are recruitable by 1) Ca , 2) increased chronotropy [heart rate (HR)], 3) stretch, and 4) β-adrenergic (β-AR) stimulation, all known physiological inotropic interventions. At the molecular level, we show that Ca increases myosin ATPase activity by shifting mavacamten-stabilized myosin heads from the inactive super-relaxed state to the active disordered relaxed state. At the myofilament level, both Ca and passive lengthening can shift mavacamten-ordered myosin heads from positions close to the thick filament backbone to disordered states closer to the thin filaments. In isolated rat cardiomyocytes, increased stimulation rates enhanced shortening fraction in mavacamten-treated cells. This observation was confirmed in vivo in telemetered rats, where left-ventricular dP/dt an index of inotropy, increased with HR in mavacamten-treated animals. Finally, we show that β-AR stimulation in vivo increases left-ventricular function and stroke volume in the setting of mavacamten. Our data demonstrate that the mavacamten-promoted states of myosin in the thick filament are at least partially activable, thus preserving cardiac reserve mechanisms.</description><subject>Animals</subject><subject>BASIC BIOLOGICAL SCIENCES</subject><subject>Benzylamines - pharmacology</subject><subject>Biological Sciences</subject><subject>Calcium</subject><subject>Calcium ions</subject><subject>Cardiac output</subject><subject>Cardiomyocytes</subject><subject>Enzymatic activity</subject><subject>Filaments</subject><subject>Heart rate</subject><subject>Muscle Contraction</subject><subject>Myocytes, Cardiac</subject><subject>Myosin</subject><subject>Myosin ATPase</subject><subject>Myosins</subject><subject>Physiology</subject><subject>Rats</subject><subject>Science &amp; Technology - Other Topics</subject><subject>Stimulation</subject><subject>Stroke volume</subject><subject>Uracil - analogs &amp; derivatives</subject><subject>Ventricle</subject><issn>0027-8424</issn><issn>1091-6490</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdkctv1DAQxiMEokvhzA1FcClS044fiZ0TQhUvqYgLnK2J7bCuEjvYzqLlr8fLlvKQLHlG85tvPP6q6imBCwKCXS4e0wVlhPeEE0ruVRsCPWk63sP9agNARSM55SfVo5RuAKBvJTysTphkvKNAN9X3j_uQnK_LwTUH57ducNmaOoxjnTJme5Zenh-iwU3uRykM-3rGHWqcs_XntUZfD7aOVsf1V2NRijYtwSdb51DSkGNYnC5RtnFnfXal9rh6MOKU7JPb-7T68vbN56v3zfWndx-uXl83mvM-N0T2TCDt0CAf7GCGEYThoxkJUI0tawl2wFEKiSBGaTrDmTTGAtcoEA07rV4ddZd1mK3RZXzESS3RzRj3KqBT_1a826qvYacIyL6lLS0Kz48KIWWnki5L6q0O3ludFeUCKJUFOrsdE8O31aasZpe0nSb0NqxJ0Z52IPpiQEFf_IfehDX68gmFYiCpkEwU6vJI6RhSina8ezIBdbBeHaxXf6wvHc_-3vSO_-01-wkt0a0B</recordid><startdate>20240220</startdate><enddate>20240220</enddate><creator>Ma, Weikang</creator><creator>Del Rio, Carlos L</creator><creator>Qi, Lin</creator><creator>Prodanovic, Momcilo</creator><creator>Mijailovich, Srboljub</creator><creator>Zambataro, Christopher</creator><creator>Gong, Henry</creator><creator>Shimkunas, Rafael</creator><creator>Gollapudi, Sampath</creator><creator>Nag, Suman</creator><creator>Irving, Thomas C</creator><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>OIOZB</scope><scope>OTOTI</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9535-7114</orcidid><orcidid>https://orcid.org/0000-0002-9761-7888</orcidid><orcidid>https://orcid.org/0000-0003-0556-1213</orcidid><orcidid>https://orcid.org/0000-0003-4848-3323</orcidid><orcidid>https://orcid.org/0000-0003-2640-3548</orcidid><orcidid>https://orcid.org/0000-0002-3770-5798</orcidid><orcidid>https://orcid.org/0000000348483323</orcidid><orcidid>https://orcid.org/0000000195357114</orcidid><orcidid>https://orcid.org/0000000305561213</orcidid><orcidid>https://orcid.org/0000000237705798</orcidid><orcidid>https://orcid.org/0000000326403548</orcidid><orcidid>https://orcid.org/0000000297617888</orcidid></search><sort><creationdate>20240220</creationdate><title>Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions</title><author>Ma, Weikang ; Del Rio, Carlos L ; Qi, Lin ; Prodanovic, Momcilo ; Mijailovich, Srboljub ; Zambataro, Christopher ; Gong, Henry ; Shimkunas, Rafael ; Gollapudi, Sampath ; Nag, Suman ; Irving, Thomas C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>BASIC BIOLOGICAL SCIENCES</topic><topic>Benzylamines - pharmacology</topic><topic>Biological Sciences</topic><topic>Calcium</topic><topic>Calcium ions</topic><topic>Cardiac output</topic><topic>Cardiomyocytes</topic><topic>Enzymatic activity</topic><topic>Filaments</topic><topic>Heart rate</topic><topic>Muscle Contraction</topic><topic>Myocytes, Cardiac</topic><topic>Myosin</topic><topic>Myosin ATPase</topic><topic>Myosins</topic><topic>Physiology</topic><topic>Rats</topic><topic>Science &amp; Technology - Other Topics</topic><topic>Stimulation</topic><topic>Stroke volume</topic><topic>Uracil - analogs &amp; derivatives</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Weikang</creatorcontrib><creatorcontrib>Del Rio, Carlos L</creatorcontrib><creatorcontrib>Qi, Lin</creatorcontrib><creatorcontrib>Prodanovic, Momcilo</creatorcontrib><creatorcontrib>Mijailovich, Srboljub</creatorcontrib><creatorcontrib>Zambataro, Christopher</creatorcontrib><creatorcontrib>Gong, Henry</creatorcontrib><creatorcontrib>Shimkunas, Rafael</creatorcontrib><creatorcontrib>Gollapudi, Sampath</creatorcontrib><creatorcontrib>Nag, Suman</creatorcontrib><creatorcontrib>Irving, Thomas C</creatorcontrib><creatorcontrib>Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV - Hybrid</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Weikang</au><au>Del Rio, Carlos L</au><au>Qi, Lin</au><au>Prodanovic, Momcilo</au><au>Mijailovich, Srboljub</au><au>Zambataro, Christopher</au><au>Gong, Henry</au><au>Shimkunas, Rafael</au><au>Gollapudi, Sampath</au><au>Nag, Suman</au><au>Irving, Thomas C</au><aucorp>Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2024-02-20</date><risdate>2024</risdate><volume>121</volume><issue>8</issue><spage>e2314914121</spage><pages>e2314914121-</pages><issn>0027-8424</issn><issn>1091-6490</issn><eissn>1091-6490</eissn><abstract>Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered states close to the thick filament backbone. It remains elusive whether these myosin heads in the state(s) can be recruited in response to physiological stimuli when required to boost cardiac output. We show that cardiac myosins stabilized in these state(s) by mavacamten are recruitable by 1) Ca , 2) increased chronotropy [heart rate (HR)], 3) stretch, and 4) β-adrenergic (β-AR) stimulation, all known physiological inotropic interventions. At the molecular level, we show that Ca increases myosin ATPase activity by shifting mavacamten-stabilized myosin heads from the inactive super-relaxed state to the active disordered relaxed state. At the myofilament level, both Ca and passive lengthening can shift mavacamten-ordered myosin heads from positions close to the thick filament backbone to disordered states closer to the thin filaments. In isolated rat cardiomyocytes, increased stimulation rates enhanced shortening fraction in mavacamten-treated cells. This observation was confirmed in vivo in telemetered rats, where left-ventricular dP/dt an index of inotropy, increased with HR in mavacamten-treated animals. Finally, we show that β-AR stimulation in vivo increases left-ventricular function and stroke volume in the setting of mavacamten. Our data demonstrate that the mavacamten-promoted states of myosin in the thick filament are at least partially activable, thus preserving cardiac reserve mechanisms.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>38346202</pmid><doi>10.1073/pnas.2314914121</doi><orcidid>https://orcid.org/0000-0001-9535-7114</orcidid><orcidid>https://orcid.org/0000-0002-9761-7888</orcidid><orcidid>https://orcid.org/0000-0003-0556-1213</orcidid><orcidid>https://orcid.org/0000-0003-4848-3323</orcidid><orcidid>https://orcid.org/0000-0003-2640-3548</orcidid><orcidid>https://orcid.org/0000-0002-3770-5798</orcidid><orcidid>https://orcid.org/0000000348483323</orcidid><orcidid>https://orcid.org/0000000195357114</orcidid><orcidid>https://orcid.org/0000000305561213</orcidid><orcidid>https://orcid.org/0000000237705798</orcidid><orcidid>https://orcid.org/0000000326403548</orcidid><orcidid>https://orcid.org/0000000297617888</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2024-02, Vol.121 (8), p.e2314914121
issn 0027-8424
1091-6490
1091-6490
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10895252
source PubMed Central
subjects Animals
BASIC BIOLOGICAL SCIENCES
Benzylamines - pharmacology
Biological Sciences
Calcium
Calcium ions
Cardiac output
Cardiomyocytes
Enzymatic activity
Filaments
Heart rate
Muscle Contraction
Myocytes, Cardiac
Myosin
Myosin ATPase
Myosins
Physiology
Rats
Science & Technology - Other Topics
Stimulation
Stroke volume
Uracil - analogs & derivatives
Ventricle
title Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A50%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myosin%20in%20autoinhibited%20off%20state(s),%20stabilized%20by%20mavacamten,%20can%20be%20recruited%20in%20response%20to%20inotropic%20interventions&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Ma,%20Weikang&rft.aucorp=Argonne%20National%20Laboratory%20(ANL),%20Argonne,%20IL%20(United%20States).%20Advanced%20Photon%20Source%20(APS)&rft.date=2024-02-20&rft.volume=121&rft.issue=8&rft.spage=e2314914121&rft.pages=e2314914121-&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.2314914121&rft_dat=%3Cproquest_pubme%3E2926079009%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-18937a26ada4bebdbf07d4fdf102ca5351a604a878a07f8d6d438dde04ca7aad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2930827837&rft_id=info:pmid/38346202&rfr_iscdi=true